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Transforming Growth Factor Beta (TGF//)
Is Produced by and Influences the Proliferative
Response of Xenopus laevis Lymphocytes
LAURA HAYNES and NICHOLAS COHEN*
Department ofMicrobiology and Immunology, University of Rochester Medical Center, Rochester, New York 14642
Both TGF/J2 and 5 have been described in the South African clawed frog Xenopus laevis
and have been cloned from the tadpole-derived fibroblast cell line, XTC. Because TGF/J
has such a profound inhibitory effect on the mammalian immune system, this study was
performed to determine whether TGF//: (a) has any in vitro effects on the growth of
Xenopus lymphoblasts, and (b) is produced by mitogen-activated Xenopus lymphocytes.
Following stimulation with mitogen or alloantigen, T lymphocytes from Xenopus
secrete a T-cell growth factor (TCGF) that is functionally homologous to mammalian
interleukin-2 (IL-2). Both recombinant human TGF/J1 and Xenopus TGFfl5 inhibit TCGF-
induced proliferation of Xenopus splenic blasts and this inhibition can be reversed with
anti-pan TGFfl antiserum. The Xenopus mitogen-induced saturated ammonium sulfate
precipitated TCGF-containing supernatant (SAS TCGF SN) also contains latent TGF//as
assayed on mink lung fibroblasts and Xenopus splenic blasts, and experiments utilizing
anti-TGF/J antiserum showed that only TGFfl5 is present in this supernatant.
KEYWORDS: TGF]/, Xenopus, immunity, lymphocyte, amphibian, cytokine.
INTRODUCTION
TGFfl is a pleiotrophic cytokine produced by a
number of different cell types including platelets,
macrophages, fibroblasts, and T and B lympho-
cytes. TGFfl is secreted in a 100-kD biologically
inactive latent form. This latency peptide can be
cleaved by a change in pH or proteolysis to yield
a 25-kD disulfide-bonded homodimer (reviewed
in Roberts and Sporn, 1990). Five types of TGF/J
have been cloned: TGFfll, 2, and 3 were orig-
inally described in humans (Assoian et al., 1983;
Wrann et al., 1987; ten Dikje et al., 1988); TGF/J4
has been found only in chickens (Jakowlew et al.,
1988); TGF//5 has been found only in Xenopus
(Roberts and Sporn, 1990). The amino-acid-
sequence identity of the aforementioned pro-
cessed TGF]/s (after cleavage of latency peptide)
is between 60% and 80%. TGF//5 is 76% identical
to TGFfll, 66% identical to TGFfl2, 69% identical
to TGF]3, and 72% identical to TGFfl4. Regions
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of identity include a highly conserved site and
nine conserved cleavage cysteine residues. TGFfl
1 through 5 also show functional conservation in
a number of assays, including the inhibition of
proliferation of mink lung fibroblasts (MLF) and
the stimulation of normal rat kidney (NRK) fibro-
blast colony formation in the presence of epider-
mal growth factor (Roberts and Sporn, 1990).
TGF//plays a role in the control of the forma-
tion of extracellular matrices, myogenesis, forma-
tion and remodeling of bone, and in embryo-
genesis. TGF// also functions in the immune
system. It inhibits T- and B-cell proliferation, NK-
cell activity, and generation of mixed lymphocyte
responses and cytotoxic T cells (Massague, 1990).
Kehrl et al. (1986) reported that TGF//is secreted
and TGFfl receptors are expressed by mitogen-
activated T cells. These and other investigators
believe that TGFfl acts to limit T- and B-cell
clonal expression and to stimulate fibroblast pro-
liferation to regulate inflammation and promote
healing.
TGFJ2 and 5 have been cloned from the Xen-
opus tadpole-derived fibroblast cell line, XTC,
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FIGURE 1. TGFfl inhibits TCGF-
induced proliferation of splenic
blasts. Representative experiment
showing 3-day-old Xenolus splenic
blasts assayed with 25%SAS TCGF
SN alone or with the indicated con-
centrations of Xenopus rTGFfl5 (A)
or human rTGFfll (B) in a 3-day 3H-
thymidine incorporation assay. The
results are expressed as mean CPM+
SE.
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and they have mesoderm-inducing activity on
explants of amphibian ectoderm (Roberts and
Sporn, 1990). Because TGFfl has such a profound
effect on the mammalian immune system, this
study was performed to determine whether
TGFfl has any in vitro effects on the growth of
Xenopus lymphoblasts and if it is produced by
mitogen-activated Xenopus lymphocytes.
RESULTS
Xenopus SAS TCGF SN contains a TCGF that is
functionally homologous to mammalian
interleukin-2 (IL-2) (Watkins and Cohen, 1987;
Haynes and Cohen, 1993). One of its main in vitro
activities is the induction of proliferation of acti-
vated, but not resting, splenocytes. Recombinant
Xenopus TGFfl5 (rTGFfl5) inhibited the SAS TCGF
SN-induced proliferation of 3-day-old Xenopus
splenic blasts (Fig. 1A). Maximum inhibition was
seen with 0.125 ng/ml and this inhibition could
be titrated until no inhibition was seen with
0.001 ng/ml. Similar results were obtained with
recombinant human TGFfll (Fig. 1B).
To determine whether the inhibition of lym-
phoblast proliferation associated with rTGFfl5
resulted from TGFfl5 or from some contaminantTRANSFORMING GROWTH FACTOR IN XENOPUS 225
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FIGURE 2. Anti-pan TGFfl anti-
serum reverses TGF/3-induced inhi-
bition of TCGF-induced prolifer-
ation. Three-day-old Xenopus
splenic blasts were cultured alone or
with 25% SAS TCGF SN and
1.25 ng/ml rTGFfl5 with or without
the indicated concentrations of rab-
bit anti-pan TGFfl or rabbit anti-
TGFfl2 antiserum, as described in
Materials and Methods, in a 3-day
3H-thymidine incorporation assay.
Results are expressed as mean CPM
+SE.
in the TGF5 preparation, TGFfl5 was preincu-
bated with anti-pan TGFfl antiserum and then
assayed (Fig. 2). Whereas the anti-pan TGFfl anti-
serum reversed the inhibition of proliferation,
the control.anti-TGFfl2 antiserum (which does
not recognize TGFfl5) did not. The observed inhi-
bition of proliferation, therefore, was specifically
due to TGFfl5. Neither antibody was mitogenic
for Xenopus blasts (Fig. 2, open bars).
The next set of experiments tested for the pres-
ence of TGFfl in the SAS TCGF SN by assaying
acid-treated (to activate latent TGFfl) SAS TCGF
SN for biological activity on mink lung fibro-
blasts and Xenopus splenic blasts. Figure 3A dem-
onstrates that rTGFfl5 inhibited the proliferation
of MLF in a dose-dependent manner; Fig. 3B
reveals that the SAS TCGF SN exhibited similar
inhibitory activity, but only upon acid activation.
Thus, PHA-stimulated Xenopus splenocytes
secrete both TCGF and a latent form of TGFfl.
Indeed, the undiluted SAS TCGF SN exhibits
activity equivalent to 125 pg/ml of rTGFfl5.
Figure 4 shows that acid-activated SAS TCGF
SN also induced reduced proliferation of Xenopus
splenic blasts when compared to untreated SN.
This reduction resulted from TGFfl activity and
not from denaturation of the TCGF molecule dur-
ing the acid treatment, because the full stimu-
latory activity of the SAS TCGF SN could be
restored when it was first treated with the anti-
pan TGFfl antiserum (Fig. 5).
Finally, because both TGFfl2 and 5 have been
described in Xenopus (Roberts and Sporn, 1990),
antiserum specific for each of these proteins was
used in an attempt to neutralize the TGFfl bio-
logical activity found in the acid-treated SAS
TGCF SN. Figure 6 shows that the anti-TGFfl2
has no effect, whereas the anti-TGFfl5 reverses
the inhibitory activity found in the acid-treated
supernatant.
DISCUSSION
In mammals, TGFfl is produced by mitogen-acti-
vated T cells, inhibits IL-2-dependent T-cell pro-
liferation, and downregulates the immune
response (Kehrl et al., 1986). Our study shows
that these observations also are applicable to the
Xenopus immune system. Xenopus splenic blasts
proliferate in response to TCGF(s) present in mit-
ogen-induced SAS TCGF SN and this prolifer-
ation can be inhibited by either rTGFfl (1 or 5) or
by activating the latent TGFfl that is present in
the supernatant. In blocking experiments with an
anti-pan TGFfl antiserum, this inhibition was
shown to result from TGFfl. Results of an
additional two experiments with antisera specific
for either TGFfl2 or TGFfl5 are consistent with
the proposition that the inhibitory effects of the
acid-activated TCGF-rich supernatant are due
solely to TGFfl5. That is, there was no reversal of
inhibition with anti-TGFfl2; the extents to which
the anti-pan TGFfl antiserum and the anti-TGFfl
5-specific antiserum reversed inhibition were
similar, and the lymphoblast growth-promoting
activity of the acid-activated supernatant was
completely restored with the anti-TGFfl5-specific226 L. HAYNES AND N. COHEN
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FIGURE 3. The effect of Xenopus TGFfl on mink lung fibroblasts. Xenopus rTGFfl5 (A) (starting concentration=0.5 ng/ml) and
Xenopus SAS TCGF SN, untreated or acid treated (acid Rx) (B) were assayed on cultures of MLF, as detailed in Materials and
Methods, for 24 hr and the cultures were then pulsed with 3H-thymidine for 6 hr. Results are expressed as mean CPM+SE. For
both experiments, CPM with medium alone was 9013.8+775; acid treatment of medium has no effect.
antiserum treatment. Whether "all" supernatants
prepared from mitogen- or antigen-stimulated
larval as well as adult Xenopus splenocytes also
contain only TGFfl5 is currently being investi-
gated. Because TGFfl is involved in development,
we are also investigating its role in the immune
system during metamorphosis to determine if the
downregulation of the immune response that is
seen during this period (Flajnik et al., 1987) is, at
least in part, attributable to TGFfl.
TGFfl activity in the SAS TCGF SN was demon-
strated by the ability of an acid-activated, but not
an untreated, supernatant to inhibit the prolifer-
ation of mink lung fibroblasts. It is not surprising
to find that both human rTGFfll and frog rTGFfl5
exhibit biological activity on frog and mammal
cells because the three types of TGFfl receptors (I,
II, and III) bind all types of TGFfl, albeit with
different affinities (Cheifetz et al., 1988; Roberts
and Sporn, 1990).
Like mammals, Xenopus has T and B lympho-
cytes and expresses class I and class II MHC mol-
ecules that function much like mammalian MHC
glycoproteins (Du Pasquier, 1989; Flajnik and DuTRANSFORMING GROWTH FACTOR IN XENOPUS 227
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FIGURE 4. SAS TCGF SN contains TGF/7 inhibitory activity for Xenopus splenic blasts. Untreated or acid Rx ASA TCGF SN, at
the indicated concentrations, was assayed on 3-day-old Xenopus splenic blasts in a 3-day 3H-thymidine incorporation assay.
Results are expressed as mean CPM+SE. L15 is the complete frog medium with 0.25% BSA.
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FIGURE 5. Anti-pan TGFfl antiserum reverses TGFfl inhibitory activity found in SAS TCGF SN. Untreated or acid Rx SAS SN
(25% per well) with or without rabbit anti-pan TGFfl or control rabbit anti-IL-la antiserum, at the indicated concentrations, was
assayed (as described in Materials and Methods) on 3-day-old Xenopus splenic blasts in a 3-day 3H-thymidine incorporation
assay. Results are expressed as mean CPM+SE.
Pasquier, 1990). Xenopus leukocytes produce an
IL-l-like cytokine (Watkins et al., 1987). Xenopus
T cells produce additional cytokines involved in
T- and B-cell proliferation (Cohen and Haynes,
1991) and also exhibit MHC-restricted cytotox-
icity (Harding, 1990). Xenopus B cells can secrete
one of three types of immunoglobulin during an
immune response, which are homologous with228 L. HAYNES AND N. COHEN
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FIGURE 6. Anti-TGFfl5, but not anti-TGFfl2, antiserum reverses TGFfl inhibitory activity found in SAS TCGF SN. Untreated or
acid Rx SAS SN (25% per well) with or without goat anti-TGFfl2, goat anti-TGFfl5, or control goat IgG, at the indicated
concentrations, was assayed (as described in Materials and Methods) on 3-day-old Xenopus splenic blasts in a 3-day 3H-thymidine
incorporation assay. Results are expressed as mean CPM+SE. CPM with medium alone is 2061.5+80.1.
mammalian IgM, IgG, and IgA (Du Pasquier,
1989). By demonstrating that Xenopus lympho-
cytes produce TGFfl that can downregulate lym-
phocyte proliferation, the present study provides
additional evidence for the remarkable similarity
of the Xenopus and mammalian immune systems.
MATERIALS AND METHODS
Animals
Fully grown adult female Xenopus laevis were
purchased from Xenopus 1 (Ann Arbor,
Michigan) or the South African Xenopus Facility
(Noordhoek, South Africa).
Production of SAS TCGF SN
SAS TCGF SN was generated as previously
described (Watkins and Cohen, 1987). Briefly, 5x
106 Xenopus splenocytes/ml were incubated at
26C in complete medium [Leibovitz’s L-15
medium (Gibco, Grand Island, New York)
adjusted to amphibian osmolarity (220 mOsm)
and supplemented with 1.25x10
-5M HEPES
buffer (Gibco), 100U/ml penicillin, 100tg/ml
streptomycin (Gibco), 1x10-aM NaHCO3, 5x
10-5M 2-mercaptoethanol (Sigma, St. Louis,
Missouri)] with 0.25% bovine serum albumin
(BSA) and I pg/ml PHA-P conjugated to agarose
beads (Sigma). Supernatants were collected from
24-hr and 48-hr cultures, pooled, and the PHA
beads were removed from the supernatant by
centrifugation. The resulting supernatant was
precipitated with saturated ammonium sulfate,
dialyzed (Spectra/Por membrane, Mr cutoff
6000-8000) with APBS, and sterile filtered before
use. All experiments described in this paper were
performed with a single batch of SAS TCGF SN.
To activate any latent TGFfl present in the SAS
TCGF SN, it was subjected to acid activation.
Five hundred microliters of SN or complete
medium was treated with 5 tl of 3N NC1 for 1 hr
at room temperature; the pH was neutralized
with 5/1 of 3N NaOH. Samples were concen-
trated using Centricon Microconcentrators
(Amicon, Beverly, Massachusetts) with a Mr cut-
off of 10,000 and then assayed.
Preparation and Assay of Splenic Blasts
Splenocytes (5x106/ml) were cultured in com-
plete medium with 10% heat-inactivated fetal
bovine serum (FBS) (Hyclone, Logan, Utah) andTRANSFORMING GROWTH FACTOR IN XENOPUS 229
1 to 2 tg/ml PHA-P (Sigma) for 3 days at 26C
in 24-well plates (Costar, Cambridge,
Massachusetts). The resulting blasts were then
centrifuged (350xg) over Histopaque =1.077
(Sigma) and washed twice in complete medium
with 1% FBS. TCGF activity was assayed on
splenic blasts in a 3-day 3H-thymidine incorpor-
ation assay. The samples were incubated with 5x
104 blasts per well (in complete L-15 with 1%
FBS) in 96-well round-bottom plates (Costar). For
antibody-inhibition experiments, samples were
incubated with antibody for 1 hr in the well
before the addition of the cells. The rabbit anti-
porcine TGFfl2 polyclonal antiserum (R & D Sys-
tems, Minneapolis, Minnesota) specifically neu-
tralizes biological activities of TGFfl2 and 3; rab-
bit anti-pan-TGFfl polyclonal antiserum (R & D
Systems) neutralizes the biological activities of
TGFfll, 2, 3, and 5. Goat anti-purified porcine
TGFfl2 and anti-recombinant Xenopus TGFfl5,
also purchased from R & D Systems, were only
used to identify the type of TGFfl in the SAS
TCGF SN (see Fig. 6). Rabbit anti-human IL-lc
(Genzyme, Boston, Massachusetts) and goat IgG
(Sigma) were also used as a negative control.
After 48 hr, 1/Ci/well 3H-thymidine
(Amersham, Arlington Heights, Illinois) was
added. The cultures were harvested after 72 hr
and processed for liquid scintillation spec-
trometry. All cultures were plated in triplicate
and the data are presented as mean counts per
minute (CPM)+SE.
Mink Lung Fibroblasts (MLF)
MLF (MvlLu CCL-64, originally from ATCC; a
gift from the laboratory of Dr. David Scott) were
maintained at 37C in 25-cm tissue-culture flasks
(Costar) in complete mouse medium [RPMI-1640
(Gibco), 100 U/ml penicillin, 0.1 mg/ml strepto-
mycin, 2mM glutamine, 0.1 mM nonessential
amino acids, 10mM HEPES, lmM sodium
pyruvate, 4.4x10
-2M sodium bicarbonate,
0.04mM 2-mercaptoethanol] with 5% FBS. To
assay for TGFfl activity, fibroblasts were ali-
quoted (2x104 per well) in complete medium with
5% FBS in 96-well flat-bottom plates (Costar) and
allowed to become confluent. The medium was
then replaced with serum-free complete mouse
medium and the cells were incubated overnight.
The serum-free medium was removed and TGFfl
(recombinant human TGFfll from R & D Systems
was provided by Dr. David Scott; recombinant
Xenopus TGF//5 was purchased from R & D
Systems) or the supernatants to be tested were
added to the cultures that were then incubated
for 24 hr. Each well was then pulsed with 1/Ci
3H-thymidine (Amersham) for 6 hr and
freeze/thawed before harvesting and processing
for liquid scintillation spectrometry. All assays
were plated in triplicate and the data are pre-
sented as the mean CPM+SE.
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